NCT03488355

Brief Summary

Positive urine cultures collected from indwelling catheters from inpatients will be randomized to standard reporting or modified reporting. Physician antibiotic treatment decisions will be prospectively observed and determined to be appropriate or inappropriate. The hypothesis is that modified reporting will lead to an increase in the percentage of appropriate therapy without an increase in pyelonephritis or sepsis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 5, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

November 5, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2019

Completed
3.5 years until next milestone

Results Posted

Study results publicly available

January 25, 2023

Completed
Last Updated

January 25, 2023

Status Verified

April 1, 2022

Enrollment Period

9 months

First QC Date

March 26, 2018

Results QC Date

October 20, 2020

Last Update Submit

April 22, 2022

Conditions

Keywords

Catheter

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Appropriate Treatment

    Untreated catheter-associated asymptomatic bacteriurias, plus treated catheter-associated urinary tract infections, divided by total patients.

    7 days after positive urine culture

Secondary Outcomes (2)

  • Death

    7 days

  • Adverse Events

    7 days after positive urine culture

Study Arms (2)

Modified Reporting

EXPERIMENTAL

Modified laboratory report

Other: Modified laboratory report

Standard Reporting

NO INTERVENTION

Standard laboratory report

Interventions

Report from microbiology laboratory: "This POSITIVE urine culture collected from an indwelling catheter may represent asymptomatic bacteriuria or urinary tract infection. If urinary tract infection is suspected clinically, please call the microbiology laboratory for identification and susceptibility results."

Modified Reporting

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • consecutive positive urine cultures collected from indwelling catheters in inpatients that are greater than or equal to 18 years of age.
  • admitted to Health Sciences Center or St. Clare's Mercy hospitals only

You may not qualify if:

  • pregnancy
  • antibiotic treatment at the time of collection
  • patients in the Intensive Care Unit
  • blood neutrophils count \<1.0 x 10E9/l, within 7 days of urine collection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Sciences Center

St. John's, Newfoundland and Labrador, A1B3V6, Canada

Location

Related Publications (1)

  • Pratt CL, Rehan Z, Xing L, Gilbert L, Fillier B, Barrett B, Daley P. Modified reporting of positive urine cultures to reduce inappropriate antibiotic treatment of catheter-associated asymptomatic bacteriuria (CA-ASB) among inpatients, a randomized controlled trial. Infect Control Hosp Epidemiol. 2021 Oct;42(10):1221-1227. doi: 10.1017/ice.2020.1397. Epub 2021 Jun 4.

MeSH Terms

Conditions

Urinary Tract Infections

Condition Hierarchy (Ancestors)

InfectionsUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Results Point of Contact

Title
Dr. Peter Daley
Organization
Memorial University of Newfoundland

Study Officials

  • Brendan Barrett, MD

    Memorial University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 26, 2018

First Posted

April 5, 2018

Study Start

November 5, 2018

Primary Completion

July 31, 2019

Study Completion

July 31, 2019

Last Updated

January 25, 2023

Results First Posted

January 25, 2023

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations